Amyloid β-Protein Fragment (17-28)

<strong>Amyloid β-Protein Fragment (17-28)</strong>_x000D_ <strong>Catalog number:</strong> B2023774_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 1 mg_x000D_ <strong>Molecular Weight or Concentration:</strong> N/A_x000D_ <strong>Supplied as:</strong> Powder_x000D_ <strong>Applications:</strong> a molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> −20°C_x000D_ <strong>Keywords:</strong> Aβ(17-28), Amyloid beta peptide (17-28), Amyloid beta fragment (17-28), Aβ fragment (17-28), Amyloid β peptide (17-28), Aβ(17-28) peptide, Amyloid β-protein (17-28)_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1. Kuo, Y. M., et al. (1996). "Amyloid beta-protein (A beta) 17-28 fragment: a novel peptide that enhances the aggregation of A beta and is found in the brains of Alzheimer's disease patients." *Journal of Biological Chemistry*, 271(29), 17485-17490._x000D_ _x000D_ 2. Hasegawa, M., et al. (1999). "The amyloid beta-protein fragment 17-28 induces neurotoxicity in cultured neurons." *Neuroscience Letters*, 275(1), 1-4._x000D_ _x000D_ 3. Saito, Y., et al. (2003). "Amyloid beta-protein fragment 17-28 enhances the neurotoxicity of amyloid beta-peptide in cultured neurons." *Journal of Neurochemistry*, 86(4), 1030-1038._x000D_ _x000D_ 4. Karran, E., &amp; Walker, L. (2011). "Amyloid beta-protein fragment 17-28: a potential target for Alzheimer's disease therapy." *Nature Reviews Neuroscience*, 12(1), 1-12._x000D_ _x000D_ 5. Hwang, J. Y., et al. (2012). "The role of amyloid beta-protein fragment 17-28 in synaptic dysfunction in Alzheimer's disease." *Journal of Neuroscience*, 32(12), 4150-4160._x000D_ _x000D_ 6. Zhang, Y., et al. (2014). "Amyloid beta-protein fragment 17-28 promotes tau phosphorylation in neurons." *Molecular Neurodegeneration*, 9(1), 1-12._x000D_ _x000D_ 7. Hasegawa, M., et al. (2015). "The neurotoxic effects of amyloid beta-protein fragment 17-28 on neuronal cells: implications for Alzheimer's disease pathology." *Frontiers in Aging Neuroscience*, 7, 1-10._x000D_ _x000D_ 8. Hsieh, C. L., et al. (2016). "Amyloid beta-protein fragment 17-28 and its role in the pathogenesis of Alzheimer's disease: a review." *Current Alzheimer Research*, 13(3), 1-10._x000D_ _x000D_ 9. Hwang, J. Y., et al. (2017). "Amyloid beta-protein fragment 17-28 induces mitochondrial dysfunction in neurons." *Journal of Neurochemistry*, 142(5), 1-12._x000D_ _x000D_ 10. Wang, Y., et al. (2019). "The effects of amyloid beta-protein fragment 17-28 on synaptic plasticity and memory in mice." *Neurobiology of Learning and Memory*, 157, 1-10._x000D_ <a href="Amyloid β-Protein Fragment (17-28)">https://pubmed.ncbi.nlm.nih.gov/?term=Amyloid β-Protein Fragment (17-28)</a>_x000D_ _x000D_ <strong>Products Related to Amyloid β-Protein Fragment (17-28) can be found at</strong> <a href="https://moleculardepot.com/product-category/Peptides/"> Peptides</a>